Rutin Attenuates Metabolic Changes, Nonalcoholic Steatohepatitis, and Cardiovascular Remodeling in High-Carbohydrate, High-Fat Diet-Fed Rats

Bravo, 1998, Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance., Nutr Rev, 56, 317, 10.1111/j.1753-4887.1998.tb01670.x Benavente-García, 2008, Updates on uses and properties ofCitrusflavonoids: new findings in anticancer, cardiovascular, and anti-inflammatory activity., J Agric Food Chem, 56, 6185, 10.1021/jf8006568 Egert, 2010, Serum lipid and blood pressure responses to quercetin vary in overweight patients by apolipoprotein E genotype., J Nutr, 140, 278, 10.3945/jn.109.117655 Rivera, 2008, Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese Zucker rats., Obesity (Silver Spring), 16, 2081, 10.1038/oby.2008.315 Mulvihill, 2009, Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistance., Diabetes, 58, 2198, 10.2337/db09-0634 Kamalakkannan, 2006, Rutin improves the antioxidant status in streptozotocin-induced diabetic rat tissues., Mol Cell Biochem, 293, 211, 10.1007/s11010-006-9244-1 Alberti, 2005, The metabolic syndrome–a new worldwide definition., Lancet, 366, 1059, 10.1016/S0140-6736(05)67402-8 Angulo, 2002, Nonalcoholic fatty liver disease., N Engl J Med, 346, 1221, 10.1056/NEJMra011775 Patton, 2010, Association between metabolic syndrome and liver histology among children with nonalcoholic fatty liver disease., Am J Gastroenterol, 105, 2093, 10.1038/ajg.2010.152 Panchal, 2011, High-carbohydrate high-fat diet-induced metabolic syndrome and cardiovascular remodeling in rats., J Cardiovasc Pharmacol, 57, 51, 10.1097/FJC.0b013e3181feb90a Bellentani, 2000, Prevalence of and risk factors for hepatic steatosis in Northern Italy., Ann Intern Med, 132, 112, 10.7326/0003-4819-132-2-200001180-00004 Bell, 2010, Serum proteomic analysis of diet-induced steatohepatitis and metabolic syndrome in the Ossabaw miniature swine., Am J Physiol Gastrointest Liver Physiol, 298, G746, 10.1152/ajpgi.00485.2009 Goland, 2006, Cardiac abnormalities as a new manifestation of nonalcoholic fatty liver disease: echocardiographic and tissue Doppler imaging assessment., J Clin Gastroenterol, 40, 949, 10.1097/01.mcg.0000225668.53673.e6 Fallo, 2009, Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension., Nutr Metab Cardiovasc Dis, 19, 646, 10.1016/j.numecd.2008.12.007 Lewis, 2010, Nonalcoholic fatty liver disease: a review and update., Dig Dis Sci, 55, 560, 10.1007/s10620-009-1081-0 Angulo, 2002, Non-alcoholic fatty liver disease., J Gastroenterol Hepatol, 17, S186, 10.1046/j.1440-1746.17.s1.10.x Fabbrini, 2010, Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications., Hepatology, 51, 679, 10.1002/hep.23280 Abdelmalek, 2007, Nonalcoholic fatty liver disease as a complication of insulin resistance., Med Clin North Am, 91, 1125, 10.1016/j.mcna.2007.06.001 Rector, 2010, Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model., J Hepatol, 52, 727, 10.1016/j.jhep.2009.11.030 Choi, 2006, Anti-adipogenic activity of rutin in 3T3–L1 cells and mice fed with high-fat diet., Biofactors, 26, 273, 10.1002/biof.5520260405 Kamalakkannan, 2006, Antihyperglycaemic and antioxidant effect of rutin, a polyphenolic flavonoid, in streptozotocin-induced diabetic Wistar rats., Basic Clin Pharmacol Toxicol, 98, 97, 10.1111/j.1742-7843.2006.pto_241.x Stanley Mainzen Prince, 2006, Rutin improves glucose homeostasis in streptozotocin diabetic tissues by altering glycolytic and gluconeogenic enzymes., J Biochem Mol Toxicol, 20, 96, 10.1002/jbt.20117 Krishna, 2005, Partial reversal by rutin and quercetin of impaired cardiac function in streptozotocin-induced diabetic rats., Can J Physiol Pharmacol, 83, 343, 10.1139/y05-009 Karthick, 2006, Preventive effect of rutin, a bioflavonoid, on lipid peroxides and antioxidants in isoproterenol-induced myocardial infarction in rats., J Pharm Pharmacol, 58, 701, 10.1211/jpp.58.5.0016 Janbaz, 2002, Protective effect of rutin on paracetamol- and CCl4-induced hepatotoxicity in rodents., Fitoterapia, 73, 557, 10.1016/S0367-326X(02)00217-4 Poudyal, 2010, Olive leaf extract attenuates cardiac, hepatic, and metabolic changes in high carbohydrate-, high fat-fed rats., J Nutr, 140, 946, 10.3945/jn.109.117812 Poudyal, 2010, Comparison of purple carrot juice and beta-carotene in a high-carbohydrate, high-fat diet-fed rat model of the metabolic syndrome., Br J Nutr, 104, 1322, 10.1017/S0007114510002308 Sim, 2003, Improved method for plasma malondialdehyde measurement by high-performance liquid chromatography using methyl malondialdehyde as an internal standard., J Chromatogr B Analyt Technol Biomed Life Sci, 785, 337, 10.1016/S1570-0232(02)00956-X Lexis, 2006, Antioxidant supplementation enhances erythrocyte antioxidant status and attenuates cyclosporine-induced vascular dysfunction., Am J Transplant, 6, 41, 10.1111/j.1600-6143.2005.01154.x Brunt, 2010, Pathology of nonalcoholic fatty liver disease., Nat Rev Gastroenterol Hepatol, 7, 195, 10.1038/nrgastro.2010.21 Targher, 2007, Non-alcoholic fatty liver disease and increased risk of cardiovascular disease., Atherosclerosis, 191, 235, 10.1016/j.atherosclerosis.2006.08.021 Lakka, 2002, The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men., JAMA, 288, 2709, 10.1001/jama.288.21.2709 Isomaa, 2001, Cardiovascular morbidity and mortality associated with the metabolic syndrome., Diabetes Care, 24, 683, 10.2337/diacare.24.4.683 Roberts, 2009, Oxidative stress and metabolic syndrome., Life Sci, 84, 705, 10.1016/j.lfs.2009.02.026 Palmieri, 2006, Systemic oxidative alterations are associated with visceral adiposity and liver steatosis in patients with metabolic syndrome., J Nutr, 136, 3022, 10.1093/jn/136.12.3022 Marsland, 2010, Systemic inflammation and the metabolic syndrome among middle-aged community volunteers., Metabolism, 59, 1801, 10.1016/j.metabol.2010.05.015 Reagan-Shaw, 2007, Dose translation from animal to human studies revisited., FASEB J, 22, 659, 10.1096/fj.07-9574LSF Scalbert, 2000, Dietary intake and bioavailability of polyphenols., J Nutr, 130, S2073, 10.1093/jn/130.8.2073S Wadworth, 1992, Hydroxyethylrutosides. A review of its pharmacology, and therapeutic efficacy in venous insufficiency and related disorders., Drugs, 44, 1013, 10.2165/00003495-199244060-00009 Belcaro, 2008, 5-year control and treatment of edema and increased capillary filtration in venous hypertension and diabetic microangiopathy using O-(β-hydroxyethyl)-rutosides: a prospective comparative clinical registry., Angiology, 59, S14, 10.1177/0003319707312683 Lund, 2002, Limb salvage instead of amputation in 10 cases of nonreconstructible ″end-point ischemia″ treated with i.v. hydroxyethylrutosides plus oral anticoagulation., Angiology, 53, 391, 10.1177/000331970205300404 Kienzler, 2002, Pharmacokinetics of mono-3’- and mono-4’-0-(beta-hydroxyethyl)-rutoside derivatives, after single doses of Venoruton powder in healthy volunteers., Eur J Clin Pharmacol, 58, 395, 10.1007/s00228-002-0472-3 Zhang, 2009, Slowly digestible starch: concept, mechanism, and proposed extended glycemic index., Crit Rev Food Sci Nutr, 49, 852, 10.1080/10408390903372466 Thirunavukkarasu, 2004, Lipoic acid attenuates hypertension and improves insulin sensitivity, kallikrein activity and nitrite levels in high fructose fed-rats., J Comp Physiol B, 174, 587, 10.1007/s00360-004-0447-z Miller, 2008, Dietary fructose and the metabolic syndrome., Curr Opin Gastroenterol, 24, 204, 10.1097/MOG.0b013e3282f3f4c4 Tappy, 2010, Metabolic effects of fructose and the worldwide increase in obesity., Physiol Rev, 90, 23, 10.1152/physrev.00019.2009 Bray, 2004, Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity., Am J Clin Nutr, 79, 537, 10.1093/ajcn/79.4.537 Choi, 2007, Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance., J Biol Chem, 282, 22678, 10.1074/jbc.M704213200 Hu, 2009, Protective effects of SP600125 in a diet-induced rat model of non-alcoholic steatohepatitis., Scand J Gastroenterol, 44, 1356, 10.3109/00365520903312441 Vanni, 2010, From the metabolic syndrome to NAFLD or vice versa?., Dig Liver Dis, 42, 320, 10.1016/j.dld.2010.01.016 Kauss, 2008, Rutoside decreases human macrophage-derived inflammatory mediators and improves clinical signs in adjuvant-induced arthritis., Arthritis Res Ther, 10, R19, 10.1186/ar2372 Guardia, 2001, Anti-inflammatory properties of plant flavonoids. Effects of rutin, quercetin and hesperidin on adjuvant arthritis in rat., Farmaco, 56, 683, 10.1016/S0014-827X(01)01111-9 Ziaee, 2009, Effects of rutin on lipid profile in hypercholesterolaemic rats., Basic Clin Pharmacol Toxicol, 104, 253, 10.1111/j.1742-7843.2008.00368.x Stewart, 2008, Quercetin transiently increases energy expenditure but persistently decreases circulating markers of inflammation in C57BL/6J mice fed a high-fat diet., Metabolism, 57, S39, 10.1016/j.metabol.2008.03.003 Rotelli, 2003, Comparative study of flavonoids in experimental models of inflammation., Pharmacol Res, 48, 601, 10.1016/S1043-6618(03)00225-1 Kim, 2005, Metabolic and pharmacological properties of rutin, a dietary quercetin glycoside, for treatment of inflammatory bowel disease., Pharm Res, 22, 1499, 10.1007/s11095-005-6250-z Kobayasi, 2010, Oxidative stress and inflammatory mediators contribute to endothelial dysfunction in high-fat diet-induced obesity in mice., J Hypertens, 28, 2111, 10.1097/HJH.0b013e32833ca68c Gkaliagkousi, 2009, Nitric oxide dysfunction in vascular endothelium and platelets: role in essential hypertension., J Hypertens, 27, 2310, 10.1097/HJH.0b013e328330e89a Thomas, 2003, Oxidative stress and endothelial nitric oxide bioactivity., Antioxid Redox Signal, 5, 181, 10.1089/152308603764816541